Search
for
Sort by
Research 30 of 1000+
- Expression and tissue distribution analysis of Angiotensin II in sheep (Ovis aries) skins associated with white and black coat colors
- Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- ACE2 Inhibits Dermal Regeneration Through Ang II in Tissue Expansion
- [Drug induced alopecia].
- Postural orthostatic tachycardia syndrome: a dermatologic perspective and successful treatment with losartan.
- Prepregnancy Phenotype and Physiological Characteristics in PCOS
- Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield
- Gender Differences in the Regulation of Blood Pressure
- DNA Damage Response Mediates Pressure Overload–Induced Cardiomyocyte Hypertrophy
- Intraoperative Floppy Iris Syndrome: Updated Perspectives
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
- Nanocarriers for Improved Delivery of Angiotensin-(1-7)
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Inhibition of Cholesterol Biosynthesis Modulates Epithelial-Mesenchymal Transition in Primary Cicatricial Alopecia Through TGFβ and Angiotensin Receptors
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Hypertension and Cicatricial Hair Loss: Defining High Value Symptom Clusters within Reproductive Aging
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- The Effect of Conditioned Medium from Angiopoietin-1 Gene-Modified Mesenchymal Stem Cells on Wound Healing in a Diabetic Mouse Model
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome